Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Fit-for-purpose application of LC-MS in protein bioanalysis, case studies shared within the European Bioanalysis Forum Hybrid MS team.

Bioanalysis·2026
Same author

Impact of ASO conjugation and receptor binding affinity on intracellular transport of mono- and bispecific TfR- and CD98-Brainshuttle<sup>TM</sup> variants.

mAbs·2026
Same author

In Vivo Clearance of Immune Complexes: Insights Into Human Drug/Anti-Drug Antibody Complex Clearance Dynamics.

The AAPS journal·2026
Same author

Implementation of the fully automated diagnostic immunoanalyzer cobas e411 in the bioanalytical laboratory - Lessons learnt.

Bioanalysis·2026
Same author

Advancing Quantitative ADA Detection Through Model Informed Assay Development (MIAD).

The AAPS journal·2026
Same author

2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS (<u>PART 3A</u> - Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity & Technologies; Biotherapeutics & Biosimilars Immunogenicity Assessment & Clinical Relevance <u>PART 3B</u> - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies).

Bioanalysis·2026

相关实验视频

Updated: Jul 26, 2025

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
08:57

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

10.0K

高离子强度解离试验减少了免疫性测试中的二维目标干扰.

Alexander Pöhler1, Cordula Jany1, Joachim Butzer2

  • 1Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalysis & Biomarkers, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany.

Bioanalysis
|June 16, 2023
PubMed
概括

高离子强度解离试验 (HISDA) 有效地减少了对抗药物抗体 (ADA) 试验中的目标干扰. 这种方法消除了二维目标的背景噪声,确保在常规药物开发中获得准确的结果.

关键词:
艾丽莎·伊丽莎·伊丽莎希斯达 (Hisda) 是一个抗药抗体是一种抗药抗体.药物耐受性 耐药性 耐药性免疫性 免疫性 免疫性带结合测定试验化酸的化是什么目标干扰的目标干扰.

更多相关视频

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

7.8K
Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
12:43

Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study

Published on: July 27, 2016

11.7K

相关实验视频

Last Updated: Jul 26, 2025

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
08:57

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

10.0K
Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

7.8K
Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
12:43

Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study

Published on: July 27, 2016

11.7K

科学领域:

  • 生物制药学分析分析
  • 免疫性测试试验的免疫性测试.
  • 测试开发的发展.

背景情况:

  • 生物样本中的可溶性度对象可以对抗药物抗体 (ADA) 试验造成干扰.
  • 这种干扰导致背景值升高和潜在的假阳性结果.
  • 准确的ADA试验开发需要减轻与目标相关的干扰.

研究的目的:

  • 评估高离子强度解离试验 (HISDA) 在减少目标干扰方面的有效性.
  • 评估HISDA对两个不同的ADA试验格式的影响.
  • 确定HISDA是否可以在存在二维标的情况下提高ADA试验的可靠性.

主要方法:

  • 将高离子强度解离试验 (HISDA) 应用于ADA试验.
  • 研究由同位体纤维细胞激活蛋白 (FAP) 引起的干扰.
  • 在高离子强度条件下,生物化学证实了同位体FAP解离.

主要成果:

  • 希斯达成功地消除了同位体FAP的干扰.
  • 在实施HISDA后,可以实现切割点的确定.
  • 生物化学测试证实,高离子强度可以解离同位体FAP.

结论:

  • 在ADA试验中,HISDA是一个有价值的工具,可以减少ADA试验中非共价结合的二维标的干扰.
  • 该测试提供了高耐药性,同时最大限度地减少了目标干扰.
  • HISDA需要最小的优化,使其适合在生物制药开发中常规使用.